DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO
| dc.contributor.author | Erez, Y. | |
| dc.contributor.author | Karakas, A. | |
| dc.contributor.author | Kocaer, S. B. | |
| dc.contributor.author | Inel, T. Yuce | |
| dc.contributor.author | Gulle, S. | |
| dc.contributor.author | Avsar, A. Koken | |
| dc.contributor.author | Onen, F. | |
| dc.date.accessioned | 2026-08-12T18:11:36Z | |
| dc.date.issued | 2020 | |
| dc.department | Fırat Üniversitesi | |
| dc.description | Annual European Congress of Rheumatology (EULAR) -- JUN 03, 2020 -- ELECTR NETWORK | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.doi | 10.1136/annrheumdis-2020-eular.2925 | |
| dc.identifier.endpage | 419 | |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.issn | 1468-2060 | |
| dc.identifier.orcid | 0000-0001-8679-2130 | |
| dc.identifier.orcid | 0000-0001-9026-9641 | |
| dc.identifier.orcid | 0000-0003-2167-4509 | |
| dc.identifier.orcid | 0000-0003-4995-430X | |
| dc.identifier.orcid | 0000-0001-8347-0873 | |
| dc.identifier.orcid | 0000-0001-5118-9307 | |
| dc.identifier.orcid | 0000-0002-4667-0603 | |
| dc.identifier.startpage | 418 | |
| dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2020-eular.2925 | |
| dc.identifier.uri | https://hdl.handle.net/11508/63746 | |
| dc.identifier.volume | 79 | |
| dc.identifier.wos | WOS:000555905001222 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Annals of the Rheumatic Diseases | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.title | DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO | |
| dc.type | Conference Object |







